Overview
| Model NO. |
BHF-VI |
| Certification |
CE, ISO13485 |
| Group |
Full Range |
| HS Code |
9027509090 |
Technology Overview
The instrument adopts reverse hybridization assay for qualitative analysis of virus sub-types. When specimens to be tested are added into specimen slot, the instrument will automatically add process-required reagent into Chip reagent slot, respectively extract DNA and amplify PCR under the drive of micro-pumps on Chip, and finally transfer amplified products to Chip test area, and the amplified products will undergo reverse hybridization with detection probe covered with virus sub-types.
If the amplified products contain amplified products of target gene, they can be captured by probe on the Chip; through enzyme reaction, there will be corresponding spots on specific position after coloration, and virus sub-type of original specimen can be judged out. If this is a negative specimen, there will be no spot on the position of probe of each virus sub-type.
Product Description
GenPlex® BHF-VI Nucleic Acid Chip Analyzer
The system consists of a host unit and an optional printer. Designed for nucleic acid detection and analysis, it is suitable for clinical screening applications such as HPV testing.
Host Unit Integrates
- ✓ Image display system
- ✓ Automated Reagent Dispensing System
- ✓ Pneumatic Control System (positive/negative pressure)
- ✓ Temperature Control System
- ✓ Image Detection System
- ✓ 3D Movable Platform System
Sample Type: exfoliated cervical epithelial cells
Technical Specifications
| Model | BHF-VI |
| Detection Platform | PCR & Reverse dot blot hybridization |
| Detection Modules | 6 Modules |
| Sample Capacity | 24 |
| Heating rate | ≥1.5 ℃/s (from 50℃ to 90℃) |
| Cooling rate | ≥1.5 ℃/s (from 90℃ to 50℃) |
| Electrical specification | 230V, 50Hz, 600VA |
| Dimension | 1000 x 610 x 690±10 (mm) |
| Altitude | ≤2300m |
| Weight | ≤80kg |
Product Features
Simple
Only 5 minutes of hands-on time required.
Easy
No precise measuring or pipetting required.
Fast
Total turnaround time of approximately 3.5 hours.
Comprehensive
24/28 target genotypes Human Papillomavirus panel.
Company Profile
Founded in 2001, our group has evolved into a high-tech biomedical enterprise that integrates R&D, production, sales, and after-sales service into a comprehensive system. The company operates a 40,000-square-meter integrated R&D center and is listed on the Shenzhen Stock Exchange ChiNext.
Why Choose Us?
We boast strong independent R&D capabilities and have established professional teams across molecular diagnosis, immunoassay, atomic absorption, and mass spectrometry. Our human trace element detection system is used in over 4,000 hospitals annually. Our microfluidic "laboratory on a chip" technology provides fully automated nucleic acid testing solutions for a wide range of medical institutions.
FAQ
Q: Can I obtain samples?
A: Yes, samples are available for evaluation.
Q: Can I use my own logo or design on the products?
A: No, we currently do not support OEM/ODM services for this specific equipment.
Q: Do you have your own manufacturing facility?
A: Absolutely! We operate a professional manufacturing factory in Beijing and welcome visits to our facilities.
Q: What is the production capacity for this analyzer?
A: Our capacity is approximately 2,000 units per month, with a reagent capacity of 1 million person-times per month.
Q: How long does shipping typically take?
A: Standard stock products are typically shipped within 7 days after order confirmation.
Q: What certifications does the BHF-VI analyzer hold?
A: The analyzer is fully certified with CE and ISO13485 standards for medical equipment.